30 Day Trial

New Indication for RTI Surgical's C-Plus Peek IBF System

Share:

RTI Surgical's C-Plus™ PEEK Interbody Fusion system is now indicated for use with allograft, including the company's proprietary map3® cellular allogeneic bone graft. This builds upon a previous indication for use solely with autograft.

Other 2016 regulatory announcements for RTI include:


Sources: RTI Surgical, Inc.; ORTHOWORLD Inc.